Orchestra BioMed Holdings (OBIO) Retained Earnings (2020 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Retained Earnings came in at -$383.3 million in Q1 2026, down 1036045.95% year-on-year from N/an in Q1 2025, and down 192.12% on a QoQ basis from $416.1 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Retained Earnings (2020 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 7 years of Retained Earnings data on file, last reported at -$383.3 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 1036045.95% year-over-year to -$383.3 million in Q1 2026; TTM through Mar 2026 was -$383.3 million, a 1036045.95% decrease from a year earlier, with the FY2025 full-year figure at $416.1 million, up 21.38% from the prior year.
- Retained Earnings for Q1 2026 stood at -$383.3 million, down from $416.1 million in the prior quarter.
- Over the last five years, Retained Earnings for OBIO reached as high as $416.1 million in Q4 2025 and fell as low as -$383.3 million in Q1 2026.
- Historically, Retained Earnings has averaged $44.3 million across 5 years, with a median of -$10000.0 in 2023.
- Across the five-year window, Retained Earnings soared 3427900.0% in 2024 and plunged 1036045.95% in 2026, its largest moves.
- Year by year, Retained Earnings stood at -$8000.0 in 2022, then slipped by 25.0% to -$10000.0 in 2023, then surged by 3427900.0% to $342.8 million in 2024, then grew by 21.38% to $416.1 million in 2025, then plunged by 192.12% to -$383.3 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$383.3 million in Q1 2026, $416.1 million in Q4 2025, and $412.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | -383.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -383.30 Mn |
| Dec 31, 2025 | 416.08 Mn |
| Sep 30, 2025 | 412.51 Mn |
| Jun 30, 2025 | 348.27 Mn |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 342.78 Mn |
| Sep 30, 2024 | -293.70 Mn |
| Jun 30, 2024 | 322.44 Mn |
| Mar 31, 2024 | -262.32 Mn |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | -236.04 Mn |
| Jun 30, 2023 | 312.25 Mn |
| Mar 31, 2023 | -210.67 Mn |
| Dec 31, 2022 | -8,000.00 |
| Sep 30, 2022 | -6.07 Mn |
| Jun 30, 2022 | -5.25 Mn |
| Mar 31, 2022 | -4.38 Mn |
| Dec 31, 2021 | -3.94 Mn |
| Sep 30, 2021 | -3.85 Mn |
| Jun 30, 2021 | -3.39 Mn |